Fundraising Fox

Prezent

Founded 2021 · 359 employees on LinkedIn · 12 known investors

Prezent is an enterprise communication and presentation productivity platform powered by AI that helps teams increase communication effectiveness and reduce presentation production time and costs. The platform serves large organizations in the F2000.

Also known as Prezent Vivo

Founders & leadership

Prezent was founded in 2021 by Rajat.

R
RajatinFounder and CEORajat previously wrote software at Microsoft and held senior leadership roles at Cisco, where he led a team of over 1,000 as a Senior Vice President. He is the founder and CEO of Prezent, an AI-powered enterprise communication and presentation platform serving Life Sciences companies.

Board

RM
Rajat Mishra

Investors · 12

Also in the syndicate · 3

Manulife VenturesTrue Global Ventures (TGV)WestWave

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Company profile

researched Aug 2026

Prezent offers an AI-based communications platform, marketed as Prezent Vivo, aimed at biopharma companies and specialized agencies. The product combines automated content generation with human expert review to produce presentations, scientific posters, advisory board reports, competitive intelligence, MSL readiness materials and similar deliverables intended to be brand-compliant and scientifically accurate.

The platform is delivered through four engagement models: a self-serve AI platform built around an AI agent called Astrid; agentic/workflow API-first agents that automate presentation creation inside other applications and workflows; an "Overnight Presentations" service in which rough drafts submitted at the end of a day are returned as polished decks the next morning under a 24-hour turnaround; and fixed-price, expert-managed projects delivered in 24-72 hours. Supporting features include an AI Builder that converts ideas, data or context files into presentations and posters, a library of expert-built slides and templates based on medical and scientific communication frameworks, a template converter that reformats existing decks to a company's brand template, and integrations that pull data from sources such as CoPilot, PubMed, Veeva and ClinicalTrials.gov plus more than 35 additional applications.

Enterprise-oriented elements described include onboarding and training by a customer success team, access controls, continuous monitoring, SSO and other compliance tooling, and a stated approach to accuracy that uses multi-layered chain-of-thought prompting combined with human validation and data privacy controls.

Business model

Prezent sells to enterprises through a mix of software subscription-style access to its self-serve AI platform and API-based workflow agents, plus service-based offerings including overnight presentation production and fixed-price, fixed-timeline managed projects positioned as an alternative to hourly agency billing.

Traction

The company reports over 5 million deliverables completed across life sciences, 150+ life sciences company customers, 45 of the top 50 biopharma firms as clients, and five years of operating history in the segment. Published customer results include a Fortune 500 biopharma citing a 70% efficiency gain and 30% reduction in agency costs, Menarini citing 12,500 hours saved and $1.1 million in agency cost savings, and Arcellyx citing $50,000 per year saved on design agencies and 10-15 hours saved per presentation. Aggregate claims include 60%-80% average time savings and 35%-85% reduction in production costs.

Full profile — market position, technology, go-to-market

Market position

Prezent positions itself as a life-sciences-specific communications partner, stating that more than 150 life sciences companies are customers and that 45 of the top 50 biopharma companies are clients.

Technology

The platform centers on Astrid, an AI agent purpose-built for life sciences that is described as understanding brand guidelines, regulatory language, audience and scientific context, and converting clinical, regulatory and commercial data into finished communications. Prezent states it reduces hallucinations through multi-layered chain-of-thought prompting and human validation, and offers API-first agents that can be embedded in customer workflows as well as live integrations with data sources including PubMed, Veeva and ClinicalTrials.gov.

Go-to-market

Prezent markets a free trial and self-serve entry point alongside enterprise sales, supported by customer success onboarding and training, published customer stories, and industry events; it promotes its own biopharma leadership conference, Articulate 2026.

Biopharma and broader life sciences companies — including medical affairs, MSL, clinical, regulatory and commercial teams — and specialized agencies serving them; the company also positions itself for large enterprise deployments.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Average time savings for customer teamsJan 202660%-80%
Deliverables completedJan 20265,000,000 deliverables
Integrations availableJan 202635 applications
Life sciences customersJan 2026150 companies
Reduction in production costsJan 202635%-85%
Top-50 biopharma companies as clientsJan 202645 companies

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 4

by search overlap

Companies competing with Prezent for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Prezent do?
Prezent is an AI communications platform for life sciences teams, combining purpose-built AI agents with human experts.
Who founded Prezent?
Prezent was founded by Rajat in 2021.
Who are Prezent's investors?
Prezent's investors include 500 Global, Angel Collective Opportunity Fund, EMERGENT VENTURES, Greycroft, Multiplier Capital, True Global Ventures, Alumni Ventures, WestWave Capital and 1 more.